Anito, Ashley O.

HRN: 27-10-59  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2025
AMPICILLIN 250MG (VIAL)
05/13/2025
05/19/2025
IVTT
190mg
Q12
Neonatal Pneumonia
Waiting Final Action 
05/13/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
05/13/2025
05/19/2025
IVTT
19mg
OD
Neonatal Pneumonia
Waiting Final Action 
05/13/2025
CEFOTAXIME 500MG (VIAL)
05/13/2025
05/20/2025
IV
180mg
Q6
MAS; Neonatal Pneumonia
Waiting Final Action 
05/18/2025
CEFTAZIDIME 1GM (VIAL)
05/18/2025
05/25/2025
IV
114mg
Q8
MAS
Waiting Final Action 
05/22/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/22/2025
05/29/2025
IV
58 Mg
Q 24
Neonatal Pneumonia
Waiting Final Action 
05/25/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/25/2025
06/01/2025
IV
380 Mg
Q 8 Hours
Neonatal Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: